Linavonkibart and pembrolizumab in immune checkpoint blockade-resistant advanced solid tumors: a phase 1 trial.
Linavonkibart 和 pembrolizumab 治疗免疫检查点阻断耐药的晚期实体瘤：一项 1 期试验。
期刊:Nature Medicine
影响因子:50
doi:10.1038/s41591-025-04157-w
Yap Timothy A, Sweis Randy F, Vaishampayan Ulka, Kilari Deepak, Gainor Justin F, McKean Meredith, Barve Minal, Tarhini Ahmad A, Bockorny Bruno, Sonpavde Guru, Park David, Babu Sunil, Ju Yawen, Liu Lan, Henry Susan, Tirucherai Giridhar S, DeWall Stephen, Qatanani Mohammed, Marantz Jing L, Gan Lu
